Patient reported outcomes used in clinical trials and core outcome sets for individuals with genetic intellectual disability: a scoping review by Nadia Y. van Silfhout, Maud M. van Muilekom, Clara D. van Karnebeek, Joost G. Daams, Lotte Haverman, Agnies M. van Eeghen

Get full text

Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorde... by Agnies M. van Eeghen, Elizabeth A. Thiele, Sam Amin, Debopam Samanta, Anna C. Jansen, Joanne Stevens, Lisa Moore-Ramdin, Petrus J. de Vries

Get full text

Protocol for EpiCom: A phase 3b/4 study of behavioral outcomes following adjunctive cannabidiol for the management of tuberous sclerosis complex-associated neuropsychiatric disorde... by Agnies M van Eeghen, Elizabeth A Thiele, Sam Amin, Debopam Samanta, Anna C Jansen, Joanne Stevens, Lisa Moore-Ramdin, Petrus J de Vries

Get full text

Validation of the self-report quantified Tuberous Sclerosis Complex-Associated Neuropsychiatric Disorders Checklist (TAND-SQ) by Nola Chambers, Tosca-Marie Heunis, Sugnet Gardner-Lubbe, Jamie K. Capal, Stacey Bissell, Anna W. Byars, Sebastián Cukier, Peter E. Davis, Jennifer Flinn, Tanjala T. Gipson, J. Chris Kingswood, Aubrey J. Kumm, Eva Schoeters, Catherine Smith, Shoba Srivastava, Megumi Takei, Stephanie Vanclooster, Agnies M. van Eeghen, Robert Waltereit, Darcy A. Krueger, Mustafa Sahin, Liesbeth De Waele, Anna C. Jansen, Petrus J. de Vries

Get full text